苏春贺;周东杨;张续;白宏英;

• 1:郑州大学第二附属医院

摘要(Abstract)：

目的分析曲唑酮片联合唑吡坦治疗失眠对睡眠障碍评定量表(SDRS)、匹兹堡睡眠质量指数(PSQI)及多导睡眠图(PSG)的影响。方法纳入120例于2018-05—2021-10于郑州大学第二附属医院接受治疗的失眠患者,A组40例施予曲唑酮片治疗,B组40例施予唑吡坦治疗,C组40例施予曲唑酮片联合唑吡坦治疗,对比3组SDRS、PSQI评分及PSG各指标。结果治疗后7 d、14 d、28 d,C组SDRS评分分别为(14.04±5.57)分、(10.15±4.32)分、(7.82±3.62)分,均较A组(18.73±6.41、12.15±5.53、11.37±4.55)、B组(18.32±5.92、12.42±4.37、11.23±4.65)低,差异均有统计学意义(P<0.05);C组PSQI评分分别为(12.29±1.29)分、(12.35±1.04)分、(7.14±0.63)分,均较A组(15.83±1.34、14.32±1.27、12.29±1.29)、B组(15.84±1.43、14.45±1.15、12.35±1.04)低,差异均有统计学意义(P<0.05);C组中PSG睡眠效率、睡眠总时间、醒觉时间、入睡时间(82.53±6.74、389.24±33.34、80.27±32.63、29.24±4.77)各项指标优于A组(74.18±6.83、333.61±34.69、120.53±33.48、36.08±4.17)、B组(73.84±7.03、334.63±35.75、120.63±34.15、35.93±3.84),差异均有统计学意义(P<0.05)。结论失眠患者给予曲唑酮片联合唑吡坦治疗效果显著,有助于改善患者的SDRS、PSQI评分及PSG指标。

关键词(KeyWords)： 失眠;曲唑酮片;唑吡坦;睡眠障碍评定量表;匹兹堡睡眠质量指数;多导睡眠图

Abstract:

Keywords:

基金项目(Foundation): 河南省医学科技攻关计划联合共建项目（编号：LHGJ20210418）

作者(Authors): 苏春贺;周东杨;张续;白宏英;

参考文献(References)：

• [1] PANCHIN Y R,VIADIMIR V M. Total Wake:Natural,Pathological,and Experimental Limits to Sleep Reduction[J]. Front Neurosci,2021,15:643496. DOI:10.3389/fnins.2021.643496.
• [2] DING F,O’DONNELL J,XU Q,et al. Changes in the composition of brain interstitial ions control the sleep-wake cycle[J]. Science,2016,352:550-555. DOI:10.1126/science.aad4821.
• [3] DUBOWY C,MORAVCEVIC K,YUE Z,et al.Genetic Dissociation of Daily Sleep and Sleep Following Thermogenetic Sleep Deprivation in Drosophila[J]. Sleep,2016,39(5):1083-1095.DOI:10.5665/sleep.5760.
• [4] CHINOY E D,CUELLAR J A,HUWA K E,et al.Performance of seven consumer sleep-tracking devices compared with polysomnography[J].Sleep,2021,44(5):zsaa291. DOI:10.1093/sleep/zsaa291.
• [5] DILLRY L C,VIGDERMAN A,WILLIAMS C E,et al. Behavioral and genetic features of sleep ontogeny in Drosophila[J].Sleep,2018,41(7):zsy086. DOI:10.1093/sleep/zsy086.
• [6] SKORUCAK J, GODESCHALK A H,ACHERMANN P,et al. Automatically Detected Microsleep Episodes in the Fitness-to-Drive Assessment[J]. Front Neurosci,2020,14:8.DOI:10.3389/fnins.2020.00008.
• [7] AMBROSIO S,LNOVO A C. Sleepiness as a Local Phenomenon[J]. Front Neurosci,2019,13:1086. DOI:10.3389/fnins.2019.01086.
• [8] FLAA T A,HARRIS A,BJORVATN B,et al.Sleepiness among personnel in the Norwegian Air Ambulance Service[J]. Int Arch Occup Environ Health,2019,92(8):1121-1130. DOI:10.1007/s00420-019-01449-w.
• [9] HUDSON,VAN DONGEN,HONN K A. Sleep deprivation,vigilant attention,and brain function:a review[J]. Neuropsychopharmacology,2020, 45(1):21-30. DOI:10.1038/s41386-019-0432-6.
• [10] RIHM J S,MENZ M M,SCHULTZ H,et al.Sleep Deprivation Selectively Upregulates an Amygdala-Hypothalamic Circuit Involved in Food Reward[J]. J Neurosci,2019,39(5):888-899. DOI:10.1523/JNEUROSCI.0250-18.2018.
• [11] BESEDOVSKY L,LANGE T,HAACK M. The Sleep-Immune Crosstalk in Health and Disease[J]. Physiol Rev,2019,99(3):1325-1380.DOI:10.1152/physrev.00010.2018.
• [12] RIEMANN D,KRONE L B,WULFF K,et al.Sleep, insomnia, anddepression[J].Neuropsychopharmacology, 2020, 45(1):74-89. DOI:10.1038/s41386-019-0411-y.
• [13] EBAN-ROTHSCHILD A,APPELBAUM L,DE LECEA L. Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive[J].Neuropsychopharmacology, 2018, 43(5):937-952. DOI:10.1038/npp.2017.294.
• [14] GOONERATNE N S,VITIELLO M V. Sleep In Older Adults:Normative Changes,Sleep Disorders and Treatment Options[J]. Clin Geriatr Med,2014,30(3):591-627. DOI:10.1016/j.cger.2014.04.007.
• [15] EDINGER J D,BUYSSE D J,DERIY L,et al.Quality Measures for the Care of Patients with Insomnia[J]. J Clin Sleep Med,2015,11(3):311-334. DOI:10.5664/jcsm.4552.
• [16] HASSINGER A B,BLETNISKY N,DUDEKULA R,et al. Selecting a pharmacotherapy regimen for patients with chronic insomnia[J]. Expert Opin Pharmacother,2020,21(9):1035-1043. DOI:10.1080/14656566.2020.1743265.
• [17] EVERITT H,BADWIN D S,STUART B,et al.Antidepressants for insomnia in adults[J].Cochrane Database Syst Rev,2018,2018(5):CD010753. DOI:10.1002/14651858.CD010753.pub2.
• [18] FAGIOLINI A,ALBERT U,FERRANDO L,et al. A randomized,double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder[J]. Int Clin Psychopharmacol,2020, 35(3):137-146. DOI:10.1097/YIC.0000000000000304.
• [19] STEELE T A,ST LOUIS E K,VIDENOVIC A,et al. Circadian Rhythm Sleep-Wake Disorders:a Contemporary Review of Neurobiology,Treatment,and Dysregulation in Neurodegenerative Disease[J]. Neurotherapeutics,2021,18(1):53-74. DOI:10.1007/s13311-021-01031-8.
• [20] DONNELLY K,BRACCHI R,HEWITT J,et al. Benzodiazepines,Z-drugs and the risk of hip fracture:A systematic review and meta-analysis[J]. PLoS One,2017,12(4):e0174730.DOI:10.1371/journal.pone.0174730.
• [21]张艳梅，马宾.酒石酸唑吡坦片治疗急性脑卒中后失眠的临床疗效[J].中国实用神经疾病杂志，2017,20(9):17-119.
• [22] ARBON E L,KNUROWSKA M,DIJK D J,et al. Randomised clinical trial of the effects of prolonged-release melatonin,temazepam and zolpidem on slow-wave activity during sleep in healthy people[J]. J psychopharmacol,2015,29(7):764-776. DOI:10.1177/0269881115581963.
• [23] RUSSELLR,MURPHY P,ZAMMIT G,et al.Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder[J]. JAMA Netw Open,2019,2(12):e1918254. DOI:10.1001/jamanetworkopen.2019.18254.
• [24] SHAYEGANI R,SONG K,AMUAN M E,et al.Patterns of zolpidem use among Iraq and Afghanistan veterans:A retrospective cohort analysis[J]. PLoS One,2018,13(1):e0190022. DOI:10.1371/journal.pone.0190022.
• [25] STALLMAN H M,KOHLER M. Prevalence of Sleepwalking:A Systematic Review and Meta-Analysis[J]. PLoS One,2016,11(11):e0164769. DOI:10.1371/journal.pone.0164769.
• [26] AHMED S,GORMAN G H,SUSI A,et al.Impact of parental injury on adolescent sleep[J]. J Clin Sleep Med,2020,16(9):1437-1444. DOI:10.5664/jcsm.8514.
• [27] VOYSEY Z J,BARKER R A,LAZAR A S,et al. The Treatment of Sleep Dysfunction in Neurodegenerative Disorders[J]. Neurotherapeutics,2021,18(1):202-216. DOI:10.1007/s13311-020-00959-7.
• [28] SMALES E T,EDWARDS B A,EYOUNG P N,et al. Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold[J]. Ann Am Thorac Soc,2015,12(5):758-764. DOI:10.1513/AnnalsATS.201408-399OC.
• [29] LA A L,WALSH C M,NEYLAN T C,et al.Long-Term Trazodone Use and Cognition:A Potential Therapeutic Role for Slow-Wave Sleep Enhancers[J]. J Alzheimers Dis,2019,67(3):911-921. DOI:10.3233/JAD-181145.
• [30]严志聪.帕罗西汀联合曲唑酮治疗抑郁症患者睡眠障碍临床效果观察[J].中国实用神经疾病杂志，2015,18(2):118-119.
• [31] ANDREW D K. Sleep therapeutics and neuropsychiatric illness[J]. Neuropsychopharmacology,2020,45(1):166-175. DOI:10.1038/s41386-019-0474-9.
• [32] VENNER A,TODD W D,FRAIGNE J,et al.Newly identified sleep-wake and circadian circuits as potential therapeutic targets[J].Sleep,2019,42(5):zsz023. DOI:10.1093/sleep/zsz023.